Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Modafinil | Phenylpiracetam | |
|---|---|---|
| Category | Nootropics | Nootropics |
| Standard Dose | 100-200 mg once daily (for educational context only — prescription medication in most jurisdictions) | 100-300 mg/day divided into 1-2 doses |
| Timing | Early morning to avoid insomnia; 1 hour before desired peak alertness. With or without food (food slows absorption by ~1 hour but does not reduce bioavailability). Half-life is approximately 12-15 hours. | Morning or early afternoon; avoid evening use due to stimulant effects. Take with or without food. |
| Cycle Duration | Not typically cycled in clinical use. Some off-label users cycle to maintain sensitivity (5 days on, 2 off; or as-needed use). | Use sparingly — tolerance develops rapidly. Best cycled 2 weeks on, 2 weeks off, or reserved for acute-need situations. |
| Evidence Level | strong_human | moderate_human |
Atypical eugeroic (wakefulness-promoting agent) that primarily inhibits the dopamine transporter (DAT), increasing extracellular dopamine in the prefrontal cortex and nucleus accumbens. This primary action cascades through multiple systems: indirect activation of orexinergic neurons in the lateral hypothalamus via potentiation of glutamatergic transmission; downstream stimulation of histaminergic neurons in the tuberomammillary nucleus (via orexin-mediated disinhibition of GABAergic inputs); and enhancement of norepinephrine release in the locus coeruleus. The net effect is broad-spectrum arousal without the peripheral sympathomimetic effects of classical stimulants.
100-200 mg once daily (for educational context only — prescription medication in most jurisdictions)
Early morning to avoid insomnia; 1 hour before desired peak alertness. With or without food (food slows absorption by ~1 hour but does not reduce bioavailability). Half-life is approximately 12-15 hours.
Not typically cycled in clinical use. Some off-label users cycle to maintain sensitivity (5 days on, 2 off; or as-needed use).
Atypical dopamine reuptake inhibitor with additional phenethylamine-like stimulatory properties. Increases the density of acetylcholine, NMDA, GABA, and dopamine receptors in the brain. The phenyl group addition to the piracetam backbone enables blood-brain barrier penetration at 20-60x greater potency than piracetam, with added psychostimulant and cold-tolerance properties.
100-300 mg/day divided into 1-2 doses
Morning or early afternoon; avoid evening use due to stimulant effects. Take with or without food.
Use sparingly — tolerance develops rapidly. Best cycled 2 weeks on, 2 weeks off, or reserved for acute-need situations.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →